IgGenix logo

IgGenix

San Francisco, CA

IgGenix is an early-stage, venture backed biotechnology company founded on breakthrough advances in Steve Quake’s laboratory at Stanford in collaboration with allergy clinician and researcher Kari Nadeau. They work on translating research discoveries into transformative therapies for individuals suf...Read more

iggenix.com

Company Details

Founded

2019

Employees

Between 10 - 50 employees

Raised

$75,000,000

Headquarters Location

San Francisco, CA

Public

No

Acquired

No

CEO

Jessica GrossmanJessica Grossman

Founders

Derek Croote
Derek Croote
Jessica Grossman
Jessica Grossman
Bruce Hironaka
Stephen Quake
Richard Boismenu
Richard Boismenu
Kari Nadeau
Kari Nadeau

Company Collections

These are collections IgGenix is a part of. Click on the collection name to view similar companies.

IgGenix's Investors

IgGenix's Industries

IgGenix's Tech Stack

IgGenix Headquarters Location

329 Oyster Point Blvd. 3rd Floor, San Francisco, CA 94080

Total Amount Raised: $75,000,000

IgGenix's Investors

IgGenix Funding Rounds

  • Series B

    $40,000,000

    Series B Investors

    Alexandria Venture Investments
    Eli Lilly and Company
    AllerFund
    Khosla Ventures
    Sean Parker

  • Series A

    $25,000,000

    Series A Investors

    Khosla Ventures
    Mattias Westman
    Alexandria Venture Investments
    Shangbay Capital
    AllerFund

  • Series A

    $10,000,000

    Series A Investors

    Khosla Ventures
    Parker Ventures
Funding info provided by Diffbot.

IgGenix Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on IgGenix.

Recent reviews